Research and Markets: Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biophar

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/c19066/technology_transfe) has announced the addition of the "Technology Transfer Strategies - A Guide to Maximizing Returns Within the Pharmaceutical and Biopharmaceutical Industries" report to their offering.

The report explores the recognized and increasing need for a better understanding between all stakeholders in the biopharmaceutical and pharmaceutical community concerning the efficient transfer of technologies created from early innovative research to the commercialization of new product technologies. The report introduces the concept of technology transfer and the organizational reasons for opting on technology transfer along with the major technologies transferred. It also provides the commercial and scientific advantages along with the analysis of challenges and issues concerning intellectual property management. It also touches upon the use of licensing in technology transfer and reviews the background to licensing. The report also analyzes the strategic options available to the biopharmaceutical and pharmaceutical industry and also predicts the future trends for technology transfer within the industry. In the last chapter, the report also analyzes the key issues concerning the technology transfer regulations and specific legislation relating to the transfer of technology in the emerging countries of Brazil, Russia, India and China.

Technology Transfer as a Key Component to Gaining Competitive Advantage

The efficient and effective transfer of new technologies is widely recognized as being a key component of gaining competitive advantage for corporations, industry and for individual nations. The rapidly changing commercial environment of the pharmaceutical industry requires that individual companies take advantage of their comparative advantages to maintain and gain competitive advantage. Senior managers need to evaluate the internal and external business environment to formulate strategies that ensures they take advantage of their strengths whilst eliminating or minimizing their recognized weaknesses. In doing so they need to determine whether and how they develop new and innovative products which can serve to fulfill an unmet clinical need in an existing market or through the creation of new markets. It is self-evident that the transfer of new technologies between academic research institutions and between companies is a key component of this creative process and essential for companies to gain and maintain competitive advantage.

Key Topics Covered:

1 Technology Transfer Strategies - Introduction

1.1 Introduction

1.2 Industry Definition

1.3 GBI Research Report Guidance

2 Technology Transfer

2.1 Technology Transfer, Overview

2.2 Reasons for Technology Transfer

2.3 Types of Technology Transfer

2.4 The Technology Transfer Process

2.5 Technology Transfer - Challenges and Critical Issues

3 Technology Transfer: Commercial and Scientific Advantages and Benefits

3.1 Introduction

3.2 Enabling the Development and Commercialization of Academic Research Findings

3.3 Commercial Considerations: Technology Transfer between Industry and Academia

3.4 Commercial Considerations in Technology Transfer: Industry and Industry

3.5 Case Studies

4 Intellectual Property Management Strategies

4.1 Overview of Intellectual Property Protection and Technology Transfer

4.2 Intellectual Property Rights Challenges and Issues

4.3 Intellectual Property Protection Strategies

4.4 Implementing Intellectual Property Strategies

4.5 Retain Ownership of Intellectual Property

4.6 Intellectual Property Protection Strategies

5 Technology Transfer and Licensing Strategies

5.1 Introduction and Background to License Agreements

5.2 The Technology Transfer Office and License Agreements

5.3 The Rationale to License Intellectual Property

5.4 In-Licensing

5.5 Out-Licensing

5.6 Preparing to License a New Technology

5.7 Negotiating Technology Transfer Licensing Agreements

5.8 Duration and Termination of License Agreements

6 Future Strategies and Opportunities for Technology Transfer

6.1 The Future of Pharmaceutical Technology Transfer

6.2 Technology Transfer by Type

6.3 Geographic Trends

6.4 Licensing and Technology Transfer between the Pharma Industry and Academia

6.5 The Integrated or Federated Model of Pharmaceutical Research

6.6 The Fully Diversified Model of Pharmaceutical Research

7 Technology Transfer Legislation and Regulation in the Emerging Markets

For more information visit http://www.researchandmarkets.com/research/c19066/technology_transfe



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.